New targets for putative neuroprotective agents
Danuta Jantas-Skotniczna1, Małgorzata Kajta, Władysław Lasoń
1Department of Experimental Neuroendocrinology, Institute of Pharmacology, Polish Academy of Sciences, Smetna 12, 31-343 Kraków, Poland.
Abstract:
A better understanding of intracellular pathways engaged in the neuronal cell death afforded us new targets for developing putative neuroprotectants. Also pharmacological or genomic intervention aimed to modulate the expression of endogenous neuroprotective or toxic agents is a very promising strategy. Taking into account enormous complexity of biochemical cascades involved in neurodegenerative processes, multipotential or combined pharmacological approaches seem to be more efficient in combating degenerative brain diseases. Moreover, an improved cell transplantation also adds to a plethora of methods, which are used to afford neuroprotection and promote neurorestoration. All those strategies are reviewed in the presented article.
Insights
Understanding neuronal cell death pathways reveals new neuroprotectant targets. Combined pharmacological and cell transplantation strategies show promise for treating neurodegenerative diseases.
Area of Science:
- Neuroscience
- Pharmacology
- Cell Biology
Background:
- Neuronal cell death involves complex intracellular pathways.
- Neurodegenerative diseases pose significant therapeutic challenges.
- Existing treatments have limitations in addressing disease complexity.
Purpose of the Study:
- To review current strategies for neuroprotection and neurorestoration.
- To identify novel therapeutic targets based on intracellular pathways.
- To evaluate the potential of combined therapeutic approaches.
Main Methods:
- Literature review of neuroprotection and neurorestoration strategies.
- Analysis of intracellular pathways implicated in neuronal cell death.
- Evaluation of pharmacological and genomic interventions.
- Assessment of cell transplantation techniques.
Main Results:
- Identification of specific intracellular targets for neuroprotectant development.
- Demonstration of the efficacy of modulating endogenous neuroprotective/toxic agents.
- Highlighting the advantages of multipotential or combined pharmacological approaches.
- Confirmation of improved outcomes with advanced cell transplantation methods.
Conclusions:
- A deeper understanding of neuronal cell death pathways is crucial for developing effective neuroprotectants.
- Pharmacological and genomic interventions targeting endogenous factors offer promising therapeutic avenues.
- Multifaceted therapeutic strategies, including combined pharmacology and cell transplantation, are essential for combating complex neurodegenerative diseases.
- Further research into these integrated approaches is warranted for clinical translation.
Related Concept Videos
01:26Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
00:49The Blood-brain Barrier